SCHEMBL6783202

SCHEMBL6783202

Cn1ncc2[nH]c3cc(F)ccc3c(=O)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.42
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 3/20 0.41
GLA P06280 2/20 0.41
GAA P10253 2/20 0.41
HTT P42858 2/20 0.41
HPGD P15428 2/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
ATM Q13315 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
PARP1 P09874 1/20 0.39
DAO P14920 1/20 0.38
CDK2 P24941 3/20 0.38
CCNE2 O96020 2/20 0.38
CDK4 P11802 2/20 0.38
CCND1 P24385 2/20 0.38
CCNE1 P24864 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6786900 0.89 KDM4E (0.51) FEN1KDM4EALDH1A1GLAGAA
SCHEMBL6787118 0.82 MPO (0.38) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6785648 0.81 KIF11 (0.47) KDM4EALDH1A1GLAHTTHPGD
SCHEMBL6791609 0.81 TBK1 (0.48) KDM4EALDH1A1GLAGAAHTT
SCHEMBL24099148 0.80 PARP1 (0.48) FEN1KDM4EHTTHPGDMEN1
SCHEMBL30380737 0.80 PARP1 (0.48) FEN1KDM4EHTTHPGDMEN1
SCHEMBL6785897 0.79 DAO (0.35) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6787155 0.79 DAO (0.38) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6792539 0.78 GRIN2D (0.36) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6781520 0.75 MEN1 (0.53) KDM4EALDH1A1GLAGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG FEN1 4449/4885KDM4E 1349/4885ALDH1A1 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.